Navigation Links
Verathon Inc. Appoints Kendall Stever as Chief Financial Officer
Date:6/25/2009

BOTHELL, Wash., June 25 /PRNewswire/ -- Verathon Inc., maker of BladderScan(R) bladder volume instruments and GlideScope(R) video laryngoscopes, announced today the appointment of Kendall Stever as Chief Financial Officer ("CFO"). Mr. Stever's responsibilities will include management and oversight of the Company's global financial affairs, including day to day financial functions for company headquarters in Washington State, taxation, investor relations as well as other company-wide financial functions. Mr. Stever will report directly to Verathon President and Chief Executive Officer Gerald McMorrow.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061011/SFW044LOGO)

Mr. Stever replaces Maureen Graham, who is retiring from Verathon after 11 years of distinguished service. Gerald McMorrow said, "I would like to thank Maureen for her outstanding commitment to Verathon's growth and development. Maureen played a key role in the company's transition from a small, entrepreneurial start-up to the global medical device manufacturer the company is today." Ms. Graham has agreed to stay on for a period of time to assist with the transition and be a key resource on other strategic initiatives.

McMorrow stated, "I am very pleased to welcome Kendall as Verathon's incoming CFO. He is a seasoned financial executive with an outstanding track record in the medical industry. His expertise, experience and energy will be a great asset to Verathon as we continue to expand our business into both new geographies and new categories of medical devices."

Mr. Stever held various financial management positions at Immunex from 1990 to 2003, when the company was sold to Amgen for $16 billion. As Immunex's Corporate Controller he oversaw all aspects of the Company's accounting organization and played key roles in the company's various strategic activities. Prior to joining Verathon, Mr. Stever headed his own consulting business, Double Diamond Consulting LLC. Mr. Stever holds a Bachelor of Science degree in Business Administration from the University of Washington.

About Verathon Inc.

Verathon designs and manufactures reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the health care community. The company's noninvasive BladderScan(R) instrument is the standard of care for noninvasive bladder volume measurement. The brand is found in over 80 countries in Urology and Primary Care practices, as well as Acute and Extended Care facilities. With the January 2006 acquisition of Saturn Biomedical Systems in Vancouver, Canada, Verathon(R) entered Anesthesiology, Critical Care and Emergency markets with the GlideScope(R) Video Laryngoscope (GVL(R)) brand. Verathon(R) is headquartered in Bothell, Washington and has over 400 employees worldwide. For more information, please visit www.verathon.com.

Media Contact: Jane Mueller, VP of Marketing, Verathon Medical, 425.867.1348, Ext. 5600. Alternate Contacts: Nansea Carmichael, Executive Assistant - Marketing, 425.867.1348, Ext. 5607; and Jessica McNerney, Executive Assistant, 425.867.1348 Ext. 5554

BladderScan, GlideScope, GVL and Verathon are trademarks of Verathon Inc.

2009 Verathon Inc.


'/>"/>
SOURCE Verathon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction
2. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Celebrates 25 Years of Improving Patient Care
3. Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms
4. GlideScope(R) Ranger Video Laryngoscope by Verathon(R) Awarded Airworthiness Certification by U.S. Army
5. Verathon Inc., Recognized, Second Year Running, as Outstanding Workplace in Washington State by Washington CEO Magazine
6. Verathon(R) Offers Enhanced BladderScan(R) Instrument as Part of Continued Program to Eliminate Unnecessary Catheterizations, Decrease Urinary Tract Infections and Assist in Hospital Infection Control
7. Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode
8. Aircraft Medical Files Counter Action Against Verathon
9. Verathon Inc., maker of GlideScope(R) Video Laryngoscopes, Introduces Free Grant Writing Kit for EMS Professionals
10. European Patent Office Upholds Verathons IP Against Aircraft Medical Challenge
11. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2007 Washington State Technology Fast 50 for 4th Time in Past 6 Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Allegheny Health Network (AHN) officials today announced a ... the Network’s programs and services in the greater Pittsburgh region. Starting January 23, patients ... offered one for that same afternoon. , AHN is the first ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... asset protection and financial planning services to communities throughout eastern Georgia, is embarking ... against heart disease. , Heart disease kills more Americans every year than anything ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... owned insurance agency which serves Lawrenceville, New Jersey and the surrounding area, ... , Amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease or ...
(Date:1/19/2017)... ... ... Attorney Robert “RC” Pate , founder of The Law Office of ... Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric cancers. In 2006, ... of the critical funding gap for research into pediatric cancer research. From 2006 onwards, ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the second ... Associates of Connecticut (RMACT) have earned “Top Doctor” awards. Dr. Mark Leondires, Dr. ... have each been chosen by their peers for the 2017 list based on ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... January 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, ... The global anti-obesity drugs market is expected ... of the forecast period and CAGR of 38.7% in the second ... at a CAGR of 32.8% from 2016 to 2027. The market ... and $24,063 million in 2027. ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017 Accuray ... its CyberKnife® and TomoTherapy® Systems continue to set the ... received the highest composite overall user satisfaction rating among ... the Q4 2016 MD Buyline Market Intelligence Briefing™. The ... the highest composite ratings among industry peers for 11 ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... Grothey ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... http://photos.prnewswire.com/prnh/20151014/276718LOGO) Published recently in ... the peer-reviewed journal from touchONCOLOGY, an article by ...
Breaking Medicine Technology: